Abstract：Objective: To investigate the effect of Wuling Capsule on the efficacy and safety of post-stroke depression patients. Methods: The subjects were 90 patients with post-stroke depression who were treated in our hospital from June 2017 to July 2018. They were simply randomly divided into treatment group (45 cases) and control group (45 cases). In the control group, patients with post-stroke depression were treated with western medicine fluoxetine, while in the treatment group, patients were treated with traditional Chinese medicine Wuling capsule. Through the treatment of two different schemes, the treatment effects of the control group and the treatment group were compared and analyzed. It mainly includes the improvement of clinical indicators and clinical treatment effect, the change of cytokines in patients after treatment and the adverse reactions of patients after treatment. Results: The HAMD score and Bi score of the treatment group were significantly higher than those of the control group (P < 0.05); the total effective rate of the treatment group was 91.67%, significantly higher than 70.00% of the control group (P < 0.05); the cytokine IL-6 and TNF - α of the treatment group were significantly lower than those of the control group (P < 0.05); compared with the control group, The rate of adverse reactions in the treatment group was significantly lower than that in the control group (P < 0.05). Conclusion: Wuling Capsule improves the clinical efficacy of patients with post-stroke depression. In terms of adverse reactions, Wuling Capsule also has a certain improvement effect.
王仕俊, 栾树鑫, 万洪泉, 田润辉, 刘畅. 乌灵胶囊对脑卒中后抑郁患者临床疗效及负性情绪的影响[J]. 河北医学, 2020, 26(1): 162-165.
WANG Shijun, LUAN Shuxin, WAN Hongquan, et al. Effect of Wuling Capsule on Clinical Efficacy and Negative Emotion in Patients with Post-stroke Depression. HeBei Med, 2020, 26(1): 162-165.
[1] Shi YZ,Xiang YT,Wu SL,et al. The relationship between frontal lobe lesions, course of post-stroke depression, and 1-year prognosis in patients with first-ever ischemic stroke[J]. PLoS One,2014,9(7):450~456. [2] Ahn DH,Lee YJ,Jeong JH,et al. The effect of post-stroke depression on rehabilitation outcome and the impact of caregiver type as a factor of post-stroke depression[J]. Ann Rehabil Med,2015,39(1):74~80. [3] Zikic TR,Divjak I,Jovicevic M,et al. The effect of post stroke depression on functional outcome and quality of life[J]. Acta Clin Croat,2014,53(3):294~301. [4] Sun N,Li QJ,Lv DM,et al. A survey on 465 patients with post-stroke depression in China[J]. Arch Psychiatr Nurs,2014,28(6):368~371. [5] Alajbegovic A,Djelilovic-Vranic J,Nakicevic A,et al. Post stroke depression[J]. Med Arch.,2014,68(1):47~50. [6] Zhang WN,Pan YH,Wang XY,et al. A prospective study of the incidence and correlated factors of post-stroke depression in China[J]. PLoS One,2013,8(11):78~81. [7] 全国脑血管病会议.各类脑血管病诊断要点[J].中华神经科杂志,1996,29(6):379. [8] 中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001.87~89. [9] Zhu J,Hu CM,Guo SS,et al. Wuling capsule played an assistant role in primary prevention of post-stroke depression: a clinical research[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi,2014,34(6):676~679. [10] 周红叶.乌灵胶囊治疗卒中后抑郁症疗效观察[J].新中医,2015,47(6):25~26. [11] 程记伟,白宇,张利军,等.乌灵胶囊治疗脑卒中后抑郁疗效及安全性Meta分析[J].中成药,2014,36(10):2049~2055. [12] Peng L,Zhang X,Kang DY,et al. Effectiveness and safety of wuling capsule for post stroke depression: a systematic review[J]. Complement Ther Med,2014,22(3):549~566.
2020, Vol. 26 
冀公网安备13080202000677号